Impaired regulation of the incretin effect in patients with type 2 diabetes

Journal of Clinical Endocrinology and Metabolism

Volumn 96, Issue 3, 2011, Pages 737-745

  Bagger, Jonatan I ^a   Knop, Filip K ^a   Lund, Asger ^a   Vestergaard, Henrik ^a   Holst, Jens J ^b   Vilsbøll, Tina ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

GASTRIC INHIBITORY POLYPEPTIDE; GLUCAGON LIKE PEPTIDE; HEMOGLOBIN A1C; INCRETIN;

ADULT; AGED; ARTICLE; BODY MASS; CHEMOLUMINESCENCE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; HEMOGLOBIN BLOOD LEVEL; HORMONAL REGULATION; HORMONE RESPONSE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; INSULIN RELEASE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; STOMACH EMPTYING; UPREGULATION;

ACETAMINOPHEN; ADULT; AGED; ANALGESICS, NON-NARCOTIC; AREA UNDER CURVE; BLOOD GLUCOSE; C-PEPTIDE; DIABETES MELLITUS, TYPE 2; FEMALE; GASTRIC EMPTYING; GASTRIC INHIBITORY POLYPEPTIDE; GLUCAGON-LIKE PEPTIDE 1; GLUCOSE; GLUCOSE TOLERANCE TEST; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INCRETINS; INSULIN; INSULIN-SECRETING CELLS; MALE; MIDDLE AGED;

EID: 79952284557     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2010-2435     Document Type: Article

References (35)

1. Creutzfeldt W, Ebert R 1985 New developments in the incretin concept. Diabetologia 28:565-573 (Pubitemid 15017390)
2. Perley M, Kipnis DM 1966 Plasma insulin responses to glucose and tolbutamide of normal weight and obese diabetic and nondiabetic subjects. Diabetes 15:867-874
3. Vilsbøll T, Holst JJ 2004 Incretins, insulin secretion and type 2 diabetes mellitus. Diabetologia 47:357-366 (Pubitemid 38491230)
4. Holst JJ 2007 The physiology of glucagon-like peptide 1. Physiol Rev 87:1409-1439 (Pubitemid 350041474)
5. Vilsbøll T, Krarup T, Madsbad S, Holst JJ 2003 Both GLP-1 and GIP are insulinotropic at basal and postprandial glucose levels and contribute nearly equally to the incretin effect of a meal in healthy subjects. Regul Pept 114:115-121 (Pubitemid 36773875)
6. Nauck M, Stöckmann F, Ebert R, Creutzfeldt W 1986 Reduced incretin effect in type 2 (non-insulin-dependent) diabetes. Diabetologia 29:46-52 (Pubitemid 16162741)
7. Nauck MA, Homberger E, Siegel EG, Allen RC, Eaton RP, Ebert R, Creutzfeldt W 1986 Incretin effects of increasing glucose loads in man calculated from venous insulin and C-peptide responses. J Clin Endocrinol Metab 63:492-498 (Pubitemid 16035703)
8. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus 2003 Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 26(Suppl 1):S5-S20
9. Bablok W, Passing H, Bender R, Schneider B 1988 A general regression procedure for method transformation. Application of linear regression procedures for method comparison studies in clinical chemistry, part III. J Clin Chem Clin Biochem 26:783-790
10. Hare KJ, Knop FK, Asmar M, Madsbad S, Deacon CF, Holst JJ, Vilsbøll T 2009 Preserved inhibitory potency of GLP-1 on glucagon secretion in type 2 diabetes mellitus. J Clin Endocrinol Metab 94:4679-4687
11. Orskov C, Rabenhøj L, Wettergren A, Kofod H, Holst JJ 1994 Tissue and plasma concentrations of amidated and glycine-extended glucagon-like peptide I in humans. Diabetes 43:535-539 (Pubitemid 24096293)
12. Krarup T, Holst JJ 1984 The heterogeneity of gastric inhibitory polypeptide in porcine and human gastrointestinal mucosa evaluated with five different antisera. Regul Pept 9:35-46 (Pubitemid 14004800)
13. Miceli JN, Aravind MK, Cohen SN, Done AK 1979 Simultaneous measurements of acetaminophen and salicylate in plasma by liquid chromatography. Clin Chem 25:1002-1004 (Pubitemid 9200955)
14. Medhus AW, Lofthus CM, Bredesen J, Husebye E 2001 Gastric emptying: the validity of the paracetamol absorption test adjusted for individual pharmacokinetics. Neurogastroenterol Motil 13:179-185 (Pubitemid 32525669)
15. Keselman HJ, Algina J, Kowalchuk RK 2001 The analysis of repeated measures designs: a review. Br J Math Stat Psychol 54:1-20 (Pubitemid 33596466)
16. Van Cauter E, Mestrez F, Sturis J, Polonsky KS 1992 Estimation of insulin secretion rates from C-peptide levels. Comparison of individual and standard kinetic parameters for C-peptide clearance. Diabetes 41:368-377
17. Kjems LL, Christiansen E, Vølund A, Bergman RN, Madsbad S 2000 Validation of methods for measurement of insulin secretion in humans in vivo. Diabetes 49:580-588 (Pubitemid 30183746)
18. Kjems LL, Vølund A, Madsbad S 2001 Quantification of β-cell function during IVGTT in type II and non-diabetic subjects: assessment of insulin secretion by mathematical methods. Diabetologia 44:1339-1348 (Pubitemid 33010513)
19. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC 1985 Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419 (Pubitemid 15018832)
20. Toft-Nielsen MB, Damholt MB, Madsbad S, Hilsted LM, Hughes TE, Michelsen BK, Holst JJ 2001 Determinants of the impaired secretion of glucagon-like peptide-1 in type 2 diabetic patients. J Clin Endocrinol Metab 86:3717-3723 (Pubitemid 32755966)
21. Vilsbøll T, Krarup T, Sonne J, Madsbad S, Vølund A, Juul AG, Holst JJ 2003 Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus. J Clin Endocrinol Metab 88:2706-2713 (Pubitemid 36724446)
22. Willms B, Werner J, Creutzfeldt W, Orskov C, Holst J, Nauck M 1994 Inhibition of gastric emptying by glucagon-like peptide (7-36) amide in patients with type-2 diabetes mellitus. Diabetologia 37:A118 (Abstract)
23. Pilichiewicz AN, Chaikomin R, Brennan IM, Wishart JM, Rayner CK, Jones KL, Smout AJ, Horowitz M, Feinle-Bisset C 2007 Load-dependent effects of duodenal glucose on glycemia, gastrointestinal hormones, antropyloroduodenal motility, and energy intake in healthy men. Am J Physiol Endocrinol Metab 293:E743-E753 (Pubitemid 47358986)
24. Willems M, Quartero AO, Numans ME 2001 How useful is paracetamol absorption as a marker of gastric emptying? A systematic literature study. Dig Dis Sci 46:2256-2262 (Pubitemid 32955241)
25. Sanaka M, Nakada K 2008 Paracetamol absorption test with Wagner-Nelson analysis for safe and accurate measurements of gastric emptying in women. Methods Find Exp Clin Pharmacol 30:753-756
26. Knop F, Bagger J, Lund A, Vestergaard H, Holst J, Vilsboll T 2009 Glucagon responses to increasing oral loads of glucose and corresponding isoglycemic intravenous glucose infusions in patients with type 2 diabetes and healthy subjects. Diabetes 58:A368 (Abstract)
27. Hansen KB, Vilsbøll T, Bagger JI, Holst JJ, Knop FK 2010 Reduced glucose tolerance and insulin resistance induced by steroid treatment, relative physical inactivity, and high-calorie diet impairs the incretin effect in healthy subjects. J Clin Endocrinol Metab 95:3309-3317
28. Vilsbøll T, Krarup T, Deacon CF, Madsbad S, Holst JJ 2001 Reduced postprandial concentrations of intact biologically active glucagon-like peptide 1 in type 2 diabetic patients. Diabetes 50:609-613 (Pubitemid 32195226)
29. Kjems LL, Holst JJ, Vølund A, Madsbad S 2003 The influence of GLP-1 on glucose-stimulated insulin secretion: effects on β-cell sensitivity in type 2 and nondiabetic subjects. Diabetes 52:380-386 (Pubitemid 36173193)
30. Vilsbøll T, Krarup T, Madsbad S, Holst JJ 2002 Defective amplification of the late phase insulin response to glucose by GIP in obese Type II diabetic patients. Diabetologia 45:1111-1119 (Pubitemid 34985287)
31. Knop F, Aaboe K, Vilsboll T, Madsbad S, Holst J, Krarup T 2008 Redcuced incretin effect in obese subjects with normal glucose tolerance as compared to lean control subjects. Diabetes 57:A410 (Abstract)
32. Knop FK, Vilsbøll T, Madsbad S, Holst JJ, Krarup T 2007 Inappropriate suppression of glucagon during OGTT but not during isoglycaemic i.v. glucose infusion contributes to the reduced incretin effect in type 2 diabetes mellitus. Diabetologia 50:797-805 (Pubitemid 46355821)
33. Højberg PV, Vilsbøll T, Rabøl R, Knop FK, Bache M, Krarup T, Holst JJ, Madsbad S 2009 Four weeks of near-normalisation of blood glucose improves the insulin response to glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide in patients with type 2 diabetes. Diabetologia 52:199-207
34. Meyer C, Stumvoll M, Nadkarni V, Dostou J, Mitrakou A, Gerich J 1998 Abnormal renal and hepatic glucose metabolism in type 2 diabetes mellitus. J Clin Invest 102:619-624 (Pubitemid 28376164)
35. Mogensen CE 1971 Maximum tubular reabsorption capacity for glucose and renal hemodynamcis during rapid hypertonic glucose infusion in normal and diabetic subjects. Scand J Clin Lab Invest 28:101-109